Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
Mid-cap Neurocrine Biosciences (NASDAQ: NBIX) continued its uptrend Thursday, along with the market-wide broad rally. MarketBeat.com - MarketBeat The stock ...
Mid-cap Neurocrine Biosciences (NASDAQ: NBIX) continued its uptrend Thursday, along with the market-wide broad rally. MarketBeat.com - MarketBeat The stock ...
Six Flags Entertainment (NYSE:SIX) is up over 13% on a day when the market is staging a relief rally of ...
Vision Hydrogen Corporation (OTCMKTS: VIHD) is a renewable energy company with a primary focus on developing clean hydrogen production facilities ...
Regulatory action has hit the semiconductor industry, which could affect the sector’s near-term prospects. Against this backdrop, we think semiconductor ...
On the surface stocks just seem to be trading calmly in a trading range. Under the surface things are setting ...
Restaurant operator The Cheesecake Factory (NASDAQ: CAKE) stock remains buoyant despite reporting a surprise loss in its Q3 2022 earnings. ...
The stock market continues to be a challenging environment with rising rates a potent headwind. So far, the economy has ...
Semiconductor company Advanced Micro Devices (NASDAQ: AMD) stock is down (-52.5%) on the year underperforming both the Nasdaq (NYSEARCA: QQQ) ...
Last week, we talked about how it felt like deja vu as the S&P 500 (SPY) embarked on its 3rd ...
The S&P 500 (SPY) may be in bear market territory, but that doesn't mean that every stock is down. In ...

Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.